3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Pancreatic Cyst
2
Neoplasms
2
Melanoma
2
Stomach Neoplasms
1
Stage IB Cervical Cancer FIGO 2018
1
Spondylitis, Ankylosing
1
Psoriasis
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Pancreatic Diseases
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Hepatitis B, Chronic
1
Giant Cell Tumor of Bone
1
Crohn Disease
1
Colitis, Ulcerative
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Bone Neoplasms
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Reactive
1
Interventions
Gene Expression Profiling
9
Blood Specimen Collection
6
Polymerase Chain Reaction
5
Immunohistochemistry
5
Amplified Fragment Length Polymorphism Analysis
5
Surveys and Questionnaires
3
Sunitinib
3
Reverse Transcriptase Polymerase Chain Reaction
3
Flow Cytometry
3
Biopsy
3
Surgical Procedures, Operative
2
Radiotherapy
2
Radiosurgery
2
Patient Reported Outcome Measures
2
Observation
2
Nivolumab
2
Microarray Analysis
2
Immunotherapy
2
Genetic Testing
2
Drug Therapy
2
DNA Methylation
2
Cytogenetic Analysis
2
tremelimumab
1
pembrolizumab
1
durvalumab
1
atezolizumab
1
aldesleukin
1
X-Rays
1
Watchful Waiting
1
Tomography, Optical Coherence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Kidney Neoplasms
×
Methods
×
Clear all
NCT04222374
2020-07-13
Uro-DNA - GWAS
University Hospital, Bordeaux
Completed
200 enrolled